◀ Back to IGF1

APOB — IGF1

Text-mined interactions from Literome

Scheidegger et al., J Biol Chem 2000 : In addition, native and oxidized LDL significantly increased IGF-1 binding protein-2 and IGF-1 binding protein-4 expression as measured by Western ligand blot
Li et al., Arterioscler Thromb Vasc Biol 2003 : We have shown previously that oxidized LDL decreases insulin-like growth factor-1 (IGF-1) and IGF-1 receptor expression in vascular smooth muscle cells and that IGF-1 and IGF-1 receptor expression are reduced in the deep intima of early atherosclerotic lesions
Ostlund et al., Mol Endocrinol 1994 : IGF-I increased LDL receptors in cultured human skin fibroblasts at concentrations greater than 25 ng/ml
Kauf et al., Med Klin (Munich) 1995 (Cystic Fibrosis) : After three months of this therapy we have seen positive metabolic ( normalized content of plasma-selenium, -glutathione peroxidase ), endocrine ( enhanced efficacy of thyroid hormones, mild increased IgF-I reduced LDL-chol ) and clinical consequences ( enhanced left ventricular cardiac output ), but in three patients side effects ( anorexia, nausea, mild hair loss ) were observed
Rudling et al., J Clin Invest 1996 : This investigation was undertaken to evaluate if these effects of GH on hepatic LDL receptors are direct or mediated by insulin-like growth factor I (IGF-I)
Hochberg et al., Eur J Clin Invest 1997 (Turner Syndrome) : IGF-I stimulated LDL degradation by 42 +/- 8 % in the control subjects and by only 16 +/- 7 % in Turner 's syndrome patients ( P < 0.05 )